Expectations for process validation: industry perspectives.
Francis
R
R
Purification Development, Biopharmaceutical Development, GlaxoSmithKline Pharmaceuticals, Beckenham, Kent, UK. rhf57363@gsk.com
D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000592:standards*; D033161:Government Regulation; D011786:Quality Control; D015203:Reproducibility of Results; D013678:Technology, Pharmaceutical / Q000331:legislation & jurisprudence / Q000592:standards*